Terumo Corporation manufactures and sells medical products and equipment worldwide. The company operates through Cardiac & Vascular, General Hospital, and Blood Management segments. Its cardiac and vascular products primarily comprise interventional devices that include access devices, such as introducer sheaths, guidewires, and guiding catheters; therapeutic devices, which include balloon catheters and stents; intravascular imaging systems; and cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and artificial thoracic vascular grafts. The company’s general hospital products principally include infusion systems, including infusion pumps, infusion solutions, IV catheter, and infusion line connectors; drug and devices comprising prefilled syringes and prefillable syringes; nutritional supplements; measuring devices systems with communication functions, such as blood glucose meters, blood pressure monitors, and thermometers; pain management medicines that include analgesic and antiemetic; and closed anticancer drug infusion systems. Its blood management products primarily comprise automated blood collection systems, blood bag systems with leukocyte reduction filters, automated blood component processing system, pathogen reduction technology systems, therapeutic apheresis systems, and cell expansion systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.
terumo corp (4543:Tokyo Stock Exchange)
44-1, 2-chome, Hatagaya
Phone: 81 3 3374 8111
|CR Bard Inc||$170.94 USD||+1.38|
|Edwards Lifesciences Corp||$127.75 USD||+0.56|
|Hospira Inc||$87.73 USD||+0.44|
|Olympus Corp||¥4,320 JPY||-20.00|
|Teleflex Inc||$124.61 USD||+2.00|
|View Industry Companies|
Sponsored Financial Commentaries
To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.